Market Place
Sourcing Support
Upstream Bio Q3 2024 Results & Recent Business Highlights
07 Nov 2024 //
GLOBENEWSWIRE
Upstream Bio Announces Closing of $293 Million Upsized IPO
15 Oct 2024 //
GLOBENEWSWIRE
Upstream swells IPO to $255M as it lists alongside CAMP4
11 Oct 2024 //
FIERCE BIOTECH
Upstream Bio, two other US biotech startups price IPOs
11 Oct 2024 //
REUTERS
Upstream Bio Announces Pricing of Upsized Initial Public Offering
10 Oct 2024 //
GLOBENEWSWIRE
CAMP4 is latest to eye IPO, while Upstream spells out $182M plan
07 Oct 2024 //
FIERCE BIOTECH
Upstream Plans IPO For Inflammation-Focused Research
19 Sep 2024 //
FIERCE BIOTECH
Upstream Bio Announces Oral Presentation Of New Data
09 Sep 2024 //
GLOBENEWSWIRE
Upstream Bio Presents Verekitug Asthma Dose Ranging At ATS
22 May 2024 //
GLOBENEWSWIRE
Upstream Bio To Present Verekitug Asthma Dose Ranging Results At ATS Conference
15 May 2024 //
GLOBENEWSWIRE
Upstream Bio Announces Appointment of Rand Sutherland as CEO
02 Apr 2024 //
BUSINESSWIRE
Upstream Bio Initiates a Phase 2 Clinical Trial of Verekitug (UPB-101)
07 Mar 2024 //
BUSINESSWIRE
Upstream Bio Announces Dosing of First Patients in Phase 2 Trial of Verekitug
03 Jan 2024 //
BUSINESSWIRE
Upstream Bio Announces Positive Phase 1b Interim Data in Asthma
24 Oct 2023 //
BUSINESSWIRE
Upstream matches first funding round with $200M to get asthma drug to PhIII
08 Jun 2023 //
ENDPTS
Upstream Bio Announces $200M Series B Financing to Advance UPB-101
08 Jun 2023 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.